Abstract:Background: Delirium is a prevalent neuropsychiatric medical phenomenon that causes serious emergency outcomes, including mortality and morbidity. It also increases the suffering and the economic burden for families and carers. Unfortunately, the pathophysiology of delirium is still unknown, which is a major obstacle to therapeutic development. The modern network-based system biology and multi-omics analysis approach has been widely used to recover the key drug target biomolecules and signaling pathways associated with disease pathophysiology. This study aimed to identify the major drug target hub-proteins associated with delirium, their regulatory molecules with functional pathways, and repurposable drug candidates for delirium treatment. Methods: We used a comprehensive proteomic seed dataset derived from a systematic literature review and the Comparative Toxicogenomics Database (CTD). An integrated multi-omics network-based bioinformatics approach was utilized in this study. The STRING database was used to construct the protein-protein interaction (PPI) network. The gene set enrichment and signaling pathways analysis, the regulatory transcription factors and microRNAs were conducted using delirium-associated genes. Finally, hub-proteins associated repurposable drugs were retrieved from CMap database. Results: We have distinguished 11 drug targeted hub-proteins (MAPK1, MAPK3, TP53, JUN, STAT3, SRC, RELA, AKT1, MAPK14, HSP90AA1 and DLG4), 5 transcription factors (FOXC1, GATA2, YY1, TFAP2A and SREBF1) and 6 microRNA (miR-375, miR-17-5, miR-17-5p, miR-106a-5p, miR-125b-5p, and miR-125a-5p) associated with delirium. The functional enrichment and pathway analysis revealed the cytokines, inflammation, postoperative pain, oxidative stress-associated pathways, developmental biology, shigellosis and cellular senescence which are closely connected with delirium development and the hallmarks of aging. The hub-proteins associated computationally identified repurposable drugs were retrieved from database. The predicted drug molecules including aspirin, irbesartan, ephedrine-(racemic), nedocromil, and guanidine were characterized as anti-inflammatory, stimulating the central nervous system, neuroprotective medication based on the existing literatures. The drug molecules may play an important role for therapeutic development against delirium if they are investigated more extensively through clinical trials and various wet lab experiments. Conclusion: This study could possibly help future research on investigating the delirium-associated therapeutic target biomarker hub-proteins and repurposed drug compounds. These results will also aid understanding of the molecular mechanisms that underlie the pathophysiology of delirium onset and molecular function.

The Pathophysiology and Biomarkers of Delirium

[Research on the mechanism of delirium based on related serum biomarkers of the delirium].

Precision‐based approaches to delirium in critical illness: A narrative review

Unravelling the pathophysiology of delirium: a focus on the role of aberrant stress responses

Biomarkers of neurodegeneration and neural injury as potential predictors for delirium

Exploration of key drug target proteins highlighting their related regulatory molecules, functional pathways and drug candidates associated with delirium: evidence from meta-data analyses

Common biomarkers of physiologic stress and associations with delirium in patients with intracerebral hemorrhage

Serum NFL and tau, but not serum UCHL-1 and GFAP or CSF SNAP-25, NPTX2, or sTREM2, correlate with delirium in a 3-year retrospective analysis

Impact of delirium on clinical outcome in critically ill patients: a meta-analysis.

Delirium and long term cognition in critically ill patients

Pharmacologic Treatment Strategies for Delirium in Hospitalized Adults: Past, Present, and Future

Common molecular and pathophysiological underpinnings of delirium and Alzheimer's disease: molecular signatures and therapeutic indications

Prevention and Management of Delirium in the Intensive Care Unit

Role of glia in delirium: proposed mechanisms and translational implications

A roadmap to advance delirium research: Recommendations from the NIDUS Scientific Think Tank

Delirium in older hospitalized patients—A prospective analysis of the detailed course of delirium in geriatric inpatients

Mechanisms underlying delirium in patients with critical illness

Preclinical and translational models for delirium: Recommendations for future research from the NIDUS delirium network

Postoperative Delirium and the Older Adult: Untangling the Confusion

Challenges of Delirium Management in Patients with Traumatic Brain Injury: From Pathophysiology to Clinical Practice

Delirium pathophysiology in cancer: neurofilament light chain biomarker – narrative review